Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.

Acta neurologica Scandinavica - 1 Dec 2007

Rodríguez-Rodríguez E, Sánchez-Juan P, Mateo I, Llorca J, Infante J, García-Gorostiaga I, Berciano J, Combarros O

Abstract excerpt

OBJECTIVE: As transforming growth factor-beta1 (TGF-beta1) determines important neurotrophic and neuroprotective actions, we postulated serum TGF-beta1 levels could be low in Alzheimer's disease (AD), and TGF-beta1 genetic variation could be associated with AD risk through modulating serum TGF-beta1 levels. METHODS: TGF-beta1 (-800) (rs 1800468), (-509) (rs 1800469) and (+869) (rs 1982073) polymorphisms were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Genetic Markers

Share to Genetic Testing

Share to Predictive Value of Tests

Share to Sensitivity and Specificity

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 17986101
DOI: 10.1111/j.1600-0404.2007.00892.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.PMID 17986101Read ↗

Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease.Semantic proximity Read ↗

Association studies of transforming growth factor-beta 1 and Alzheimer's disease.Semantic proximity Read ↗

Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer's disease.Semantic proximity Read ↗

Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study.Semantic proximity Read ↗

+10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution.Semantic proximity Read ↗

Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease.Semantic proximity Read ↗

The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.Semantic proximity Read ↗

Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease.Semantic proximity Read ↗

Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population.Semantic proximity Read ↗

Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease.Semantic proximity Read ↗

No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.Semantic proximity Read ↗

No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.